GLP-1 TV
Not Losing Weight on GLP-1? My Doctor Finally Explained Why
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this weekly update from the channel the channel, the speaker says she is in week six of 10 mg on Mounjaro and takes her week seven injection on camera. She started in June of 2025 and says her most significant loss was 32 lb, after which her weight began to creep back up. She describes her frustration with the scale and with online comments that assume she must be overeating.
Published by Slow & Steady with Andi on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
The main segment covers an appointment this week. According to the speaker, her doctor told her that her A1C was 5.4, down from a high of 7.9, and that it has been 5.4 for her last three visits. The doctor also noted improvements in her vitals and strength. The speaker says the doctor explained that many people starting a GLP-1 medication eat a lot, so appetite suppression creates a sudden large calorie deficit and fast fat loss. People whose starting point is different, such as those with insulin resistance, PCOS or type 2 diabetes, may not see the same drop. The speaker says she was already eating in a balanced way, often struggling to reach the 1600 to 1800 calories her nutritionist set.
The speaker reports that she and her doctor agreed on moving to the next dose, 12.5 mg, though she plans a few more weeks at 10 mg. She says the doctor advised against cutting calories further and suggested more activity, especially HIT workouts. Her short-term goal is to lose 10 more pounds by her birthday on May 4th. She says she injects in her thighs and arms rather than her belly, because she gets better appetite suppression and food noise relief that way.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:00 The speaker says she is in week six of 10 mg Mounjaro and will take her week seven injection in this video.
- 5:24 She says she started in June of 2025, lost at most 32 lb, and then saw her weight rise again.
- 5:54 Her doctor told her that her A1C was 5.4, compared with a past high of 7.9, and that it has held at 5.4 for three visits.
- 7:56 The doctor explained that people who overeat before starting a GLP-1 see fast loss from a sudden calorie deficit, while those with a different starting point may lose more slowly.
- 13:13 The speaker and her doctor decided on the next dose, and the doctor advised against lowering calories and in favor of more activity such as HIT workouts.
- 16:56 The speaker says she injects in her thighs and arms because she got no appetite suppression or food noise relief from belly injections.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Mounjaro
- Side effects mentioned
- low appetite
Questions this video answers
Why is she not losing weight fast on Mounjaro?
According to the speaker, her doctor explained that people who lose quickly often start out eating a lot, so appetite suppression creates a large calorie deficit. The speaker says she was already eating in a balanced way, so her body did not get that same shock.
What A1C did the speaker reach on Mounjaro?
The speaker says her A1C is 5.4, down from a high of 7.9, and that it has been 5.4 for her last three visits. She says her doctor told her the medicine did what it was supposed to do.
Where does the speaker inject Mounjaro and why?
She says she injects in her thighs and arms and no longer uses her belly. She reports that belly injections gave her no appetite suppression or food noise relief.
What did the speaker's doctor advise about calories and exercise?
The speaker says her doctor did not want her to lower her calories below the 1600 to 1800 range, since a lower amount would make a balanced diabetic plate hard. The doctor suggested increasing activity instead, especially HIT workouts.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Lose 50 lbs in 39 Weeks: First GLP-1 Shot to MaintenanceShe says she is not a doctor and that this is her personal experience.- What a GLP-1 costs at every program we trackToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
Wow!😲MOUNJARO 3 Month Results😲|5mg | WEIGHT LOSS, Blood Sugar Levels, etc | 90 Days on TirzepatideThe speaker, who says she has been diagnosed with type 2 diabetes in the past, gives a 90 day update on taking Mounjaro.
I TRIED A GLP-1 FOR 3 MONTHS!The channel, a beauty creator, documents about three months on a GLP-1 medication, starting in January and wrapping up at the beginning of May.
9 months of mounjaro... a personal updateThe channel, who describes herself as a doctor, gives a personal update on her time taking Mounjaro and answers viewer questions.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- GLP-1 vs GLP-2 vs GLP-3: what the names mean, and which ones you can actually buy
GLP-1 drugs such as semaglutide act on one receptor. "GLP-2" is used online for tirzepatide (Zepbound, Mounjaro), which acts on two, GIP and GLP-1, and "GLP-3" for retatrutide, which adds the glucagon receptor. Neither nickname is the real name: GLP-2 is a separate gut hormone whose drug, Gattex, treats short bowel syndrome. Retatrutide produced 28.3% mean weight loss at 80 weeks in its phase 3 trial but is not FDA-approved; Lilly plans to file in Q1 2027. Tirzepatide is the strongest option you can buy today.
- Stopping a GLP-1: what the withdrawal trials found, and what a maintenance dose actually is
Two trials have measured what happens when you stop. On semaglutide, people who lost 17.3% over 68 weeks regained two-thirds of it in the year after stopping, ending 5.6% below where they started. On tirzepatide, people who lost 20.9% in 36 weeks regained 14% over the next year on placebo while those who continued lost a further 5.5%. Both labels are explicit that these drugs are for maintaining weight reduction long term, which is a different claim from finishing a course. A maintenance dose is simply the dose you stay on; the labels do not define a lower one to step down to at goal.
Next steps
Mounjaro prices
Find more like it
Dose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsInjection techniqueExercise and strengthStopping and maintenanceLow appetite
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















